Private AI Health Companies Expert insights, guides, and stories about health

Medical News

FDA’s AI Warning: De-Risking Due Diligence for Cardiac AI Investors

Aug 2, 2026

FDA’s AI Warning: De-Risking Due Diligence for Cardiac AI Investors

Eko Health: 9 FDA Clearances, Capital-Efficient Cardiac AI Growth

Jul 23, 2026

Eko Health: 9 FDA Clearances, Capital-Efficient Cardiac AI Growth

Intuitive Surgical: Why Healthcare AI Compounding Beats Hypergrowth

Jul 23, 2026

Intuitive Surgical: Why Healthcare AI Compounding Beats Hypergrowth

iRhythm’s 70% Monopoly: A Golden Opportunity for Cardiac AI Challengers

Jul 23, 2026

iRhythm’s 70% Monopoly: A Golden Opportunity for Cardiac AI Challengers

Clover Health: Does its AI-Powered CDS Model Deliver?

Jul 23, 2026

Clover Health: Does its AI-Powered CDS Model Deliver?

Health Data Platforms: Billion Dollar Revenue Engines for VCs

Jul 23, 2026

Health Data Platforms: Billion Dollar Revenue Engines for VCs

FDA Enforcement: De-Risking Cardiac AI Investments

Jul 23, 2026

FDA Enforcement: De-Risking Cardiac AI Investments

Agilon Health: The $1.4 Billion Public VBC Platform Driving Full-Risk Capitation

Jul 22, 2026

Agilon Health: The $1.4 Billion Public VBC Platform Driving Full-Risk Capitation

CVS’s $10.6 Billion Oak Street Buy: VBC Validation for AI Investors

Jul 22, 2026

CVS’s $10.6 Billion Oak Street Buy: VBC Validation for AI Investors

Anumana’s AI Moat: FDA to CPT for Recurring Revenue

Jul 22, 2026

Anumana’s AI Moat: FDA to CPT for Recurring Revenue